Published Date: 30 Sep 2026
Here's some of what is coming soon to NeurologyLive® this week.
Read Full NewsIn a discrete choice experiment, somnolence risk and short-term efficacy were the top factors driving vesicular monoamine transporter 2 inhibitor selection for tardive dyskinesia in patients aged 55 years and older.
FDA approves once-daily oral tavapadon for Parkinson disease, a first-in-class D1/D5 partial agonist that improves motor function and ON time, with key safety warnings.
New PREVAIL trial analyses presented at the 2026 AANEM Annual Meeting showed gefurulimab reduced gMG-related hospitalizations and produced durable symptom and quality-of-life gains through one year.
PridCor Therapeutics is moving its phase 2 SHIELD trial of a combination antiviral regimen toward enrollment, building on case series data showing durable symptom improvement in long COVID.
New phase 3 MINT trial analyses presented at the 2026 AANEM Annual Meeting showed inebilizumab produced sustained improvement in MuSK-positive gMG regardless of time since diagnosis.
A joint ESC/ERA guideline on universal CKD screening headlines August 2026's nephrology news, alongside new finerenone and sibeprenlimab trial data.
Targeting Gut Candida to Treat IBD, With Iliyan D. Iliev, PhD
1.
Is Vitamin D a Key to Better Breast Cancer Survival?
2.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
3.
What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips?
4.
US Cancer Trials Heavily Favor Single Drugs Over Care Issues
5.
Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win
1.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
2.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
3.
Quality of Life Following Functional Restoration of Bone Marrow Reserve
4.
Next-Generation Bone Marrow Harvest Technologies
5.
All You Need to Know About Mesna: The Ultimate Guide
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
How Blood Tests Help Detect Hematological Disorders
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation